Industry veteran Joy Brownstein joins firm with 30+ years of experience in biopharma to help lead growing business
September 1, 2022, FAIRFIELD, CT, US – Global healthcare communications consultancy 90TEN, part of Envision Pharma Group, today announced it has hired industry veteran Joy Brownstein as part of its expanding growth plans in the US market.
Previously a consultant at 90TEN, Brownstein will report to Kate Paxton, US Head, 90TEN, and will continue to be a key leader of current client business. Brownstein will also work with Paxton on the continued growth of 90TEN’s US operation, leveraging the existing rich resources within Envision Pharma Group for US client needs and showcasing 90TEN and its unique culture and approach.
“We are thrilled to have such an experienced and passionate professional like Joy join the growing 90TEN team,” said Paxton. “Joy’s long history of building strategic and creative programs for healthcare clients of every size and scope – in addition to her deep understanding of how agencies grow and thrive – makes her ideally suited to help lead the 90TEN US team through this next, exciting phase.”
Brownstein has more than 30 years of experience in healthcare marketing and communications, working at agencies like BCW, Syneos Health, and Ketchum on product communications, advocacy relations, corporate communications, and issues management. Her clients have included biotech companies, pharmaceutical organizations, medical device companies, healthcare providers, third party disease awareness and patient advocacy groups.
Brownstein’s work has won numerous awards; these include a Gold SABRE Award for the Best Public Education Campaign of the Year for the “T2 Dance Crew” which was a diabetes campaign for Janssen Pharmaceuticals in partnership with the Diabetes Hands Foundation and the television program, So You Think You Can Dance.
“90TEN’s focus on changing people’s healthcare behaviors – not just communicating about them – really impressed me,” said Brownstein. “The agency’s proprietary approach to clients’ healthcare communications challenges is more sophisticated and effective than other agencies. I wanted to be part of a team that really changes people’s lives.”
90TEN has worked with behavioral psychologists to develop its own Feel-Think-Do™ evidence-based suite of tools to analyze human emotions, thought processes, and environmental factors that affect each healthcare communications challenge. These tools can be applied to every brief to deliver insightful, tailored, and targeted communications that are designed to inspire meaningful and positive change. This approach, along with a culture that celebrates innovation, allows 90TEN to be creative and scientific in execution and strategy.
Headquartered in London, UK, 90TEN employs around 70 members of staff and works with half of the top 20 pharma companies in the world serving clients across Europe and North America. In 2020 it became part of Envision Pharma Group – a global provider of evidence-based communication services and industry-leading technology solutions.
About 90TEN
90TEN, part of the Envision Pharma Group, is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and communications. 90TEN provides PR, medical communications, and patient advocacy services that use behavioral science methodologies to maximize brand and health outcomes. 90TEN is one of the leading healthcare communications consultancies in Europe and in 2020 it was named Communications Consultancy of the Year at both the Communiqué Awards and SABRE EMEA Awards. To find out more, visit www.90TENHealth.com
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a global, technology-enabled scientific communications company serving pharmaceutical, biotechnology, and medical device companies. As a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision) that have applicability across many areas of medical affairs and related functional responsibility, Envision provides scientific communication services and technology solutions to more than 90 companies, including 19 of the top 20 pharmaceutical companies. Learn more at: www.envisionpharmagroup.com
For further information:
Marsha Caplin
Global Head of Marketing
Envision Pharma Group
Email: marsha.caplin@envisionpharmagroup.com
Tel: +44 (0)7557 083549
